SESSION TITLE: PAH
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Sunday, October 23, 2016 at 01:30 PM - 03:00 PM
PURPOSE: With the advent of the new oral anti-coagulants (NOAC), early discharge of patients with acute pulmonary embolism (PE) at a low risk (LR) for mortality based on Pulmonary Embolism Severity Index (PESI) and/or HESTIA criteria has been described as potentially safe and effective. To our knowledge, there are no studies describing early discharge of intermediate low (ILR) or intermediate high risk (IHR) PE patients using NOAC’s. We hypothesized that acute PE patients with ILR and IHR for mortality can be safely and quickly discharged on NOAC’s with close outpatient follow-up.